Quasi-Experimental Evaluation of the Effectiveness of a Large-Scale Readmission Reduction Program
Jenq GY, Doyle MM, Belton BM, Herrin J, Horwitz LI. Quasi-Experimental Evaluation of the Effectiveness of a Large-Scale Readmission Reduction Program. JAMA Internal Medicine 2016, 176: 681. PMID: 27065180, DOI: 10.1001/jamainternmed.2016.0833.Peer-Reviewed Original ResearchConceptsDischarge patientsReadmissions Reduction ProgramControl populationReadmission ratesIntervention periodSame-hospital readmission ratesUrban academic medical centerTarget populationAdjusted readmission ratesOdds of readmissionHigh-risk patientsZip codesAdjusted admission ratesInterrupted time series analysisAcademic medical centerQuasi-experimental evaluationLogistic regression modelsReduction programsDischarge dispositionReadmission reduction effortsComparative interrupted time series analysisMedication reconciliationService patientsMean ageTransitional careImpact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications
Gershman B, Van Houten HK, Herrin J, Moreira DM, Kim SP, Shah ND, Karnes RJ. Impact of Prostate-specific Antigen (PSA) Screening Trials and Revised PSA Screening Guidelines on Rates of Prostate Biopsy and Postbiopsy Complications. European Urology 2016, 71: 55-65. PMID: 26995328, DOI: 10.1016/j.eururo.2016.03.015.Peer-Reviewed Original ResearchConceptsRate of biopsyProstate-specific antigen (PSA) screeningPredictors of complicationsPostbiopsy complicationsUSPSTF recommendationsAntigen screeningProstate biopsyRelative morbidityScreening TrialUS Preventive Services Task Force (USPSTF) recommendationOvarian Cancer Screening TrialAmerican Urological Association guidelinesMorbidity of biopsyPrior fluoroquinolone useEuropean Randomized StudyCancer Screening TrialInterrupted time series analysisProportion of menTask Force recommendationsInfectious complicationsAnticoagulant useComplication rateUnderwent biopsyRandomized studyScreening guidelines